Nearly 40 life-saving medications manufactured by Glenmark Pharmaceuticals Inc. have been recalled by the U.S. Food and Drug ...

With 88 years of legacy, Chung Mei Pharmaceutical is transforming into a global leader in healthcare innovation, driven by ...

With extensive experience in manufacturing APIs, advanced intermediates and specialty chemicals, SCI Pharmtech is one of ...

The Illinois expansion will happen at the company’s headquarter campus in Abbott Park. It's also growing in Dallas.

Nearly 40 generic medications targeting heart and brain illnesses produced by Glenmark Pharmaceuticals have been recalled by ...

Divi's Laboratories signs a long-term supply agreement with a global pharmaceuticals company for advanced intermediates. The deal is expected to bring significant revenue to Divi's.

Divi's Labs said it will invest Rs 650-700 crore in capacity expansion and that it eyes significant revenue boost ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

The Trump administration has declared the lack of medicine production in the US a national security threat, which means ...

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...